IRhythm Holdings Profit Margin 2015-2025 | IRTC
Current and historical gross margin, operating margin and net profit margin for IRhythm Holdings (IRTC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. IRhythm Holdings net profit margin as of September 30, 2025 is -7.32%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.904B | $0.592B |
| IRHYTHM HLDGS is a digital health care company which creates trusted solutions that detect, predict and prevent disease. IRHYTHM HLDGS, formerly known as iRhythm Technologies Inc., is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.738B | 35.55 |
| Tempus AI (TEM) | United States | $9.941B | 0.00 |
| Doximity (DOCS) | United States | $5.129B | 21.79 |
| Hims & Hers Health (HIMS) | United States | $3.925B | 31.93 |
| Privia Health (PRVA) | United States | $2.684B | 167.85 |
| Hinge Health (HNGE) | United States | $2.602B | 0.00 |
| 10x Genomics (TXG) | United States | $2.423B | 0.00 |
| Heartflow (HTFL) | United States | $2.325B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.980B | 32.76 |
| Omnicell (OMCL) | United States | $1.750B | 48.75 |
| Azenta (AZTA) | United States | $1.381B | 55.54 |
| Enovis (ENOV) | United States | $1.291B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.095B | 0.00 |
| Schrodinger (SDGR) | United States | $1.004B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.861B | 0.00 |
| Phreesia (PHR) | United States | $0.748B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.713B | 0.00 |
| Talkspace (TALK) | United States | $0.646B | 130.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Claritev (CTEV) | United States | $0.365B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.338B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.285B | 13.10 |
| CapsoVision (CV) | United States | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.146B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 5.49 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.015B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |